Provided By Business Wire
Last update: Feb 21, 2025
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. (“Doximity”) (NYSE: DOCS) breached their fiduciary duties to Doximity and its shareholders.
Scott+Scott is investigating whether members of Doximity’s board of directors or senior management failed to manage Doximity in an acceptable manner, in breach of their fiduciary duties to Doximity, and whether Doximity and its shareholders have suffered damages as a result.
On August 8, 2023, Doximity provided disappointing guidance for the second quarter of fiscal year 2024 and slashed its guidance for the full fiscal year 2024. In conjunction with the disappointing guidance, Doximity announced that it would reduce its workforce by approximately 10%. Doximity further noted that the workforce reduction was expected to cost approximately $8 million to $10 million. On this news, the price of Doximity common stock declined $7.49 per share, or nearly 23%, from a close of $32.79 per share on August 8, 2023, to close at $25.30 per share on August 9, 2023.
On April 1, 2024, Jehoshaphat Research published a report alleging, among other things, that “Doximity’s underlying sales . . . are declining at a negative -3-6% rate, but that this decline has been masked through accelerated revenue recognition.” On this news, the price of Doximity common stock declined $1.11 per share, to close at $25.80 per share on April 2, 2024.
What You Can Do – CLICK HERE FOR YOUR OPTIONS AS A SHAREHOLDER
If you own shares of Doximity, you may have legal claims against Doximity’s directors and officers. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.
About Us
Scott+Scott is an international law firm known for its expertise in representing corporate clients, institutional investors, businesses, and individuals harmed by anticompetitive conduct or other forms of wrongdoings, including securities law and shareholder violations.
With more than 100 attorneys in nine offices in the United States, as well as three offices in Europe, our advocacy has resulted in significant monetary settlements on behalf of our clients, along with other forms of relief.
Our highly experienced attorneys have been recognized for being among the top financial lawyers in 2024 by Lawdragon, WWL: Commercial Litigation 2024, and Legal 500 in Antitrust Civil Litigation, and have received top Chambers 2024 rankings. In addition, we have been recognized by the American Antitrust Institute for the successful litigation of high-stakes anticompetitive claims in the United States.
To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit www.scott-scott.com.
Attorney Advertising
View source version on businesswire.com: https://www.businesswire.com/news/home/20250221881753/en/
72.37
-2.63 (-3.51%)
Find more stocks in the Stock Screener
A fundamental analysis of (NYSE:DOCS): Should Quality-Oriented Investors Explore DOXIMITY INC-CLASS A (NYSE:DOCS)?
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.
Discover the top movers in Friday's pre-market session and stay informed about market dynamics.
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Uncover the potential of DOXIMITY INC-CLASS A, a growth stock reasonably priced. NYSE:DOCS is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation.